The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPredator Oil Regulatory News (PRD)

Share Price Information for Predator Oil (PRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (11.765%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.00
PRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Share Options

7 Oct 2022 09:19

RNS Number : 1627C
Predator Oil & Gas Holdings PLC
07 October 2022
 

 

FOR IMMEDIATE RELEASE

7 October 2022

 

Predator Oil & Gas Holdings Plc / Index: LSE / Epic: PRD / Sector: Oil & Gas

LEI 213800L7QXFURBFLDS54

Predator Oil & Gas Holdings Plc

("Predator" or the "Company" and together with its subsidiaries "the Group")

 

 Exercise of Share Options

Predator Oil & Gas Holdings Plc (LSE: PRD), the Jersey based Oil and Gas Company with near-term gas operations focussed on Morocco, announces that it has received an exercise notice from Sarah Cope, a former director, in respect of share options issued to her pursuant to the Company's unapproved share option scheme.:

dated 18 May 2018 (at the date of the Company's admission to the Official List (standard listing segment) of the London Stock Exchange's main market for listed securities) to subscribe for 1,001,370 new shares of no par value each in the Company ("New Ordinary Shares") at 2.8p per share.

The Company has therefore allotted and issued the total of 1,001,370 New Ordinary Shares following receipt of the aggregate £28,038.36 subscription price from Sarah Cope. These shares rank pari passu with the existing ordinary shares of the Company. Application will be made to the Financial Conduct Authority ("FCA") for the New Ordinary Shares to be admitted to listing on the Official List (standard listing segment) of the FCA and to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on the London Stock Exchange's main market for listed securities (together "Admission"). It is expected that Admission will become effective at 8.00 a.m. on 12 October 2022.

The Company advises that, following this Admission, the Company's issued share capital will be 355,598,217 shares of no par value, each with one vote per share (and no such shares are held in treasury). The total number of voting rights is therefore 355,598,217.

The above figure of 355,598,217 may be used by shareholders as the denominator for the calculations to determine if they have a notifiable interest in the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules, or if such interest has changed.

 

Directors' Holdings

The positions held by the Directors are as follows:

 

 

 

 

DIRECTOR

TOTAL SHARES

OPTIONS

18 May 2018

OPTIONS

27 October 2020

OPTIONS

31 January 2022

OPTIONS

5 July 2022

Paul Griffiths

30,085,793*

4,005,486

3,850,000

Nil

Nil

Lonny

Baumgardner

555,600

Nil

Nil

7,855,486

Nil

Alistar Jury

Nil

Nil

Nil

Nil

2,000,000

Tom Evans

Nil

Nil

Nil

Nil

2,000,000

 

Details of the 2018 and 2020 option awards may be found in the Company's annual report.

Options issued on 5 July 2022 are exercisable at 8.125 pence per share, being the closing mid-market price on 4 July 2022, and will vest after 6 months.

 

Total Options and Warrants on issue

Following the exercise of the share options by Sarah Cope, the total options and warrants outstanding in the Company are as follows:

 

OPTIONS

18 May 2018¹

OPTIONS

27 October 2020²

WARRANTS³

OPTIONS 

31 January 20224

OPTIONS 

5 July 2022⁵

Directors 

4,005,486

7,150,000

Nil

8,855,486

4,000,000

Previous directors

3,300,000

Nil

1,000,000

Advisers

and others

Nil

Nil

5,974,468

Nil

 

1) 18/5/18 options are exercisable at 2.8 pence per share

(2) 27/10/20 options are exercisable at 5 pence per share

(3) Warrants include outstanding warrants issued to Company advisers at

an exercise price of 2.8 pence per share (160,718 on 24 May 2018), 12 pence per share (2,000,000 on 15 February 2019), 4 pence per share (2,193,750 on 17 February 2020), 10.5 pence per share (1,020,000 on 12 March 2021), 15 pence per share (600,000 on 18 June 2021), 9 pence per share (690,000 on 28 March 2022) and 5.5 pence per share (3,600,000 on 23 August 2022). Further details of the 2018, 2019, 2020 and 2021 warrant awards may be found in the Company's 2021 Annual Report and Financial Statements.

(4) 8,855,486 options are exercisable at 5.66 pence per share.

(5) 4,000,000 options are exercisable at 8.125 pence per share.

 

If all options and warrants were to become exercisable and then exercised in accordance with their terms, gross proceeds received by the Company would be £2,023,225.

For further information visit www.predatoroilandgas.com

 

Follow the Company on twitter @PredatorOilGas.

 

This announcement contains inside information for the purposes of Article 7 of the Regulation (EU) No 596/2014 on market abuse

For more information please visit the Company's website at www.predatoroilandgas.com

 

Enquiries:

Predator Oil & Gas Holdings Plc

Paul Griffiths Executive Chairman

Lonny Baumgardner Managing Director

Tel: +44 (0) 1534 834 600

Info@predatoroilandgas.com

Novum Securities Limited

Jon Belliss

 

Optiva Securities Limited

Christian Dennis

 

Tel: +44 (0) 207 399 9425

 

 

Tel: +44 (0) 203 137 1902

 

 

 

Flagstaff Strategic and Investor Communications

Tim Thompson 

Mark Edwards

Fergus Mellon

 

 

Tel: +44 (0) 207 129 1474

predator@flagstaffcomms.com

 

Notes to Editors:

 

Predator is operator of the Guercif Petroleum Agreement onshore Morocco which is prospective for Tertiary gas in prospects less than 10 kilometres from the Maghreb gas pipeline. The MOU-1 well has been completed and a follow-up testing programme is being finalised to coordinate with a further drilling programme beginning in 2022.

 

Predator is seeking to further develop the remaining oil reserves of Trinidad's mature onshore oil fields through the application of CO2 EOR techniques and by sequestrating anthropogenic carbon dioxide to produce "greener" oil.

 

In addition, Predator also owns and operates exploration and appraisal assets in licensing options offshore Ireland, for which successor authorisations have been applied for, adjoining Vermilion's Corrib gas field in the Slyne Basin on the Atlantic Margin and east of the decommissioned Kinsale gas field in the Celtic Sea.

 

Predator has developed a Floating Storage and Regasification Project ("FSRUP") for the import of LNG and its regassification for Ireland and is also developing gas storage concepts to address security of gas supply and volatility in gas prices during times of peak gas demand.

 

The Company has a highly experienced management team with a proven track record in operations in the oil and gas industry.

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFSWSAWEESEFS
Date   Source Headline
13th May 20097:00 amRNSFirst Quarter Results
11th May 200910:02 amRNSMonthly Commentary
5th May 200911:50 amRNSNet Asset Value(s)
23rd Apr 20094:37 pmRNSAnnual Report and Accounts
23rd Apr 20094:36 pmRNSNotice of AGM
17th Apr 20099:16 amRNSNotice of Results
14th Apr 20099:34 amRNSMonthly Investor Commentary
7th Apr 200911:38 amRNSResult of EGM
3rd Apr 20092:55 pmRNSDirector/PDMR Shareholding
2nd Apr 20092:35 pmRNSNet Asset Value(s)
16th Mar 20093:03 pmRNSAnnual Results
11th Mar 20095:17 pmRNSNotice of EGM
11th Mar 20099:20 amRNSMONTHLY INVESTOR COMMENTARY
10th Mar 20094:55 pmRNSHolding(s) in Company
3rd Mar 200910:27 amRNSNet Asset Value(s)
27th Feb 20094:26 pmRNSAnnual Information Update
25th Feb 20095:13 pmRNSSterling Conversion
24th Feb 20091:25 pmRNSNotice of EGM
10th Feb 20099:53 amRNSMonthly Commentary
10th Feb 20097:01 amRNSDividend Announcement
10th Feb 20097:00 amRNSFourth Quarter Results
5th Feb 20094:17 pmRNSHolding(s) in Company
3rd Feb 200910:44 amRNSNet Asset Value(s)
30th Jan 20099:23 amRNSNotice of Results
9th Jan 200910:52 amRNSMonthly Commentary
6th Jan 20094:35 pmRNSPrice Monitoring Extension
5th Jan 20094:55 pmRNSDirector/PDMR Shareholding
5th Jan 200910:48 amRNSNet Asset Value(s)
24th Dec 200811:11 amRNSHolding(s) in Company
11th Dec 20089:58 amRNSMonthly Commentary
4th Dec 200811:20 amRNSResult of EGM
2nd Dec 20084:35 pmRNSPrice Monitoring Extension
2nd Dec 200810:45 amRNSNet Asset Value(s)
27th Nov 20084:44 pmRNSHolding(s) in Company
24th Nov 20084:41 pmRNSPrice Monitoring Extension
24th Nov 20084:20 pmRNSHolding(s) in Company
24th Nov 20084:11 pmRNSHolding(s) in Company
19th Nov 20084:00 pmRNSSterling Conversion Re: Q3 2008 Dividend
11th Nov 20089:12 amRNSMonthly Commentary
7th Nov 20084:45 pmRNSNotice of EGM
4th Nov 20087:00 amRNSDividend Declaration
4th Nov 20087:00 amRNSMonthly NAV
4th Nov 20087:00 amRNSNotice of EGM
4th Nov 20087:00 amRNSThird Quarter Results
15th Oct 20083:18 pmRNSNotice of Results - Amendment
15th Oct 20089:19 amRNSNotice of Results
8th Oct 20089:08 amRNSMonthly Commentary
2nd Oct 200812:15 pmRNSNet Asset Value(s)
23rd Sep 200811:37 amRNSDirector/PDMR Shareholding
10th Sep 20089:06 amRNSInvestor Commentary

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.